Scarlet fever does not reliably go away on its own, and it should not be left untreated. The infection sometimes improves without antibiotics, but the risk of serious complications is real and the evidence has been clear since the mid-20th century. Penicillin-era studies showed that untreated streptococcal infections carried far higher rates of rheumatic fever and other sequelae than treated ones . Modern guidance from the CDC and the American Academy of Pediatrics is unambiguous: every confirmed case of scarlet fever should receive antibiotics . So the honest answer is "sometimes, but you should not bet on it."
Scarlet fever is a toxin-mediated illness caused by group A Streptococcus (GAS), usually Streptococcus pyogenes. It is not a separate infection from strep throat. It is strep throat (or sometimes a skin infection) plus a specific bacteriophage that carries the gene for a scarlet fever toxin. That distinction matters because it explains almost everything about how the disease behaves, why it responds to penicillin, and why untreated cases can produce immune complications weeks later.
Mechanism: toxin plus bacteria
The rash of scarlet fever is not the bacterium itself. It is the immune system reacting to an exotoxin called streptococcal pyrogenic exotoxin (SpeA, SpeB, SpeC, and others). Only GAS strains infected by a lysogenic bacteriophage carrying the spe gene produce these toxins. A child can have severe strep throat and no rash if their strain lacks the phage. Another child with the same throat infection and a toxin-producing strain develops the full scarlet fever picture.
The toxin drives a characteristic sequence. It causes capillary dilation in the skin, which produces the diffuse erythematous "sunburn" rash, and it triggers inflammation of the tongue papillae, giving the "strawberry tongue." The rash typically appears 12 to 48 hours after fever onset and starts on the neck, chest, and groin before spreading. Desquamation, or peeling, follows one to three weeks later, especially on the fingers, toes, and groin.
The bacterial component matters because GAS itself causes the invasive and immune-mediated damage. The bacteria adhere to pharyngeal epithelium, produce streptolysin and other enzymes, and provoke an antibody response. In a minority of untreated patients, that antibody response cross-reacts with heart valve tissue (rheumatic fever) or kidney glomeruli (post-streptococcal glomerulonephritis). Antibiotics do not just shorten the illness; they reduce the bacterial load and interrupt the immune cascade that produces these complications.
A crucial mechanistic point: antibiotics kill the bacteria, but they do not neutralize toxin already circulating. This is why a child can remain febrile and rashy for 24 to 48 hours after the first dose even though the antibiotic is working. It also means antibiotics do not treat the rash directly. They treat the infection behind it.
How often does it resolve without treatment, and how bad is that path?
Historical data before routine penicillin use give the clearest numbers. In the pre-antibiotic era, untreated scarlet fever carried a case fatality rate that varied by outbreak and era, with reported figures in the range of roughly 5 to 20 percent during severe epidemics in the 19th century, falling substantially by the 20th century. Those figures come from an era before modern supportive care, so they overstate today's risk. What they establish is that scarlet fever was historically a lethal disease, not a benign rash.
More useful is the complication data. Untreated GAS pharyngitis produces rheumatic fever in roughly 0.3 to 3 percent of cases in outbreak settings, with wide geographic variation. The classic figure from military outbreaks in the 1940s and 1950s is around 3 percent. Treated cases reduce that risk by roughly 70 to 90 percent, and the classic randomized trial evidence supporting this comes from the Warren Air Force Base studies published in the 1950s .
Post-streptococcal glomerulonephritis is a different complication with a different mechanism. It can follow both throat and skin infections, and the evidence that antibiotics prevent it is weaker than for rheumatic fever. Some outbreaks show no reduction in nephritis with treatment. This is one of the genuinely counterintuitive points: antibiotics reliably prevent rheumatic fever but do not reliably prevent all kidney complications.
Current invasive GAS disease incidence in the United States is roughly 3 to 6 cases per 100,000 population per year, with higher rates in children under 5 and adults over 65 . Scarlet fever itself is not notifiable in most US jurisdictions, so precise national counts are limited. Estimates from syndromic surveillance suggest tens of thousands of pediatric cases annually in the US, with cyclical increases every several years and a notable global resurgence in the 2010s and 2020s in the UK and parts of Asia.
The time course: what actually happens week by week
Understanding the timeline clarifies why treatment timing matters and what parents should watch for.
| Phase | Timing | Typical features |
|---|---|---|
| Incubation | 2–5 days | Asymptomatic; contagious period begins |
| Fever and sore throat | Day 0–2 | Abrupt fever, pharyngitis, headache, vomiting |
| Rash onset | 12–48 hours after fever | Diffuse erythema on neck, chest, groin |
| Strawberry tongue | Day 2–4 | White coating then red papillae |
| Peak illness | Day 2–5 | Rash most intense, fever may persist |
| Antibiotic effect | 24–48 hours after first dose | Fever falls, rash fades, contagiousness drops |
| Desquamation | Day 7–21 | Peeling of fingers, toes, groin |
| Complication window | Week 2–4 | Rheumatic fever, glomerulonephritis (if untreated) |
The key number in this table is the 24-hour mark. A patient with scarlet fever is considered non-contagious roughly 24 hours after starting appropriate antibiotics . Without antibiotics, contagiousness persists for one to two weeks or longer. That single fact drives school exclusion policies and household transmission control.
Where the "it goes away on its own" belief comes from
The belief is not irrational. Many viral rashes resolve without treatment, and parents reasonably generalize. The rash of scarlet fever does fade. Fever does break. A child often looks better within a week even without antibiotics. The illness "going away" is what a parent observes, and observation is a weak instrument for detecting a complication that appears three weeks later.
The other source is the historical decline of scarlet fever severity. Case fatality fell dramatically in the late 19th and early 20th centuries before antibiotics existed, due to improved nutrition, hygiene, and supportive care. This created a widespread perception that scarlet fever became "mild." Severity did decline, and modern cases are generally milder than Victorian-era cases. But "milder" is not "harmless," and the rheumatic fever risk persisted.
There is also a genuine scientific uncertainty worth stating plainly. Modern case series of untreated scarlet fever are small, and much of the complication rate data comes from pharyngitis studies rather than scarlet fever specifically, since scarlet fever is a subset of GAS pharyngitis. We extrapolate. The extrapolation is well-supported by mechanism, but it is an extrapolation.
Practical actions and red flags
The practical threshold is simple: any child with sore throat plus fever should be evaluated, and a rash should prompt the same. Rapid antigen detection tests and throat cultures are standard in US primary care. A positive test in a patient with scarlet fever features means antibiotics, full stop.
Concrete actions:
Get a rapid strep test or culture for any sore throat with fever, especially in children aged 5 to 15, the peak incidence group. If scarlet fever features are present (rash, strawberry tongue, sandpaper texture), treat as scarlet fever even if the rapid test is negative, and confirm with culture. Complete the full antibiotic course even if the child feels better in 48 hours; the treatment duration for GAS pharyngitis is typically 10 days for oral penicillin or amoxicillin. Keep the child home until at least 24 hours of antibiotics have been taken and fever has resolved. Watch for complications in the 2 to 4 weeks after illness: joint pain, new fever, dark urine, facial swelling, or breathlessness.
Red flags that require urgent evaluation:
Difficulty breathing, drooling, or inability to swallow liquids. Decreased urine output, dark cola-colored urine, or facial or leg swelling after the illness. Joint swelling or migratory joint pain two to four weeks after the sore throat. Persistent fever beyond 48 to 72 hours on antibiotics. Severe pain or swelling of the neck, or a muffled "hot potato" voice, suggesting a deep neck abscess.
Comparing outcomes: treated vs. untreated
| Outcome | Untreated GAS pharyngitis | Treated with appropriate antibiotics |
|---|---|---|
| Symptom duration | 7–10 days | 3–4 days faster resolution |
| Contagious period | 1–2 weeks or longer | Ends ~24 hours after first dose |
| Rheumatic fever risk | ~0.3–3% in outbreak settings | Reduced 70–90% |
| Glomerulonephritis risk | Present; not reliably reduced by treatment | |
| Peritonsillar or retropharyngeal abscess | Low but real risk | Reduced but not eliminated |
| Invasive GAS disease | Rare but serious | Reduced with prompt treatment |
The glomerulonephritis row deserves explanation. The data on whether antibiotics prevent post-streptococcal glomerulonephritis are inconsistent. Some studies show benefit, others show none. The prevailing interpretation is that nephritis is driven by immune complex deposition from a strain-specific antigen, and early antibiotic treatment may not always arrive before that process begins. This is a genuine reason a treated child can still develop nephritis, and it is a reason parents should not interpret "the antibiotic failed" if kidney symptoms appear later. It means the complication was already in motion.
A professional caveat worth knowing
The AAP and CDC both recommend antibiotics for all confirmed GAS pharyngitis, and scarlet fever is treated as a more severe manifestation rather than a milder one . There has been professional debate about whether asymptomatic carriers need treatment, and the answer is generally no. That debate does not apply to scarlet fever, because scarlet fever implies symptomatic invasive infection.
There is one more caveat: penicillin allergy. For patients with true IgE-mediated penicillin allergy, azithromycin or cephalosporins (with appropriate caution) are alternatives, per IDSA guidance . The choice depends on reaction type and is a clinical decision. This is the point where self-treatment or delayed treatment causes the most avoidable harm.
A final limitation: much of the complication-rate literature predates modern molecular diagnostics, and modern case definitions vary. The direction of the evidence is solid. The exact numbers carry uncertainty.
Where this leaves the question
Scarlet fever can, in some patients, resolve without antibiotics. The fever breaks and the rash fades. What does not reliably resolve is the bacterial carriage and the downstream immune risk. The CDC position is that GAS pharyngitis should be treated to prevent rheumatic fever, and scarlet fever is treated as such . The AAP Red Book is aligned . WHO guidance on GAS pharyngitis similarly supports antibiotic treatment where available .
The practical answer for a parent or patient is: do not wait it out. Get tested, get treated, finish the course, and watch the 2-to-4-week window. The illness is usually manageable and the treatment is usually simple. The complication that justifies treatment appears after the child looks well again, which is precisely why the "it went away" impression is dangerous.
References
Denny FW, Wannamaker LW, Brink WR, Rammelkamp CH Jr, Custer EA. Prevention of rheumatic fever: treatment of the preceding streptococcic infection. JAMA. 1950;143(17):1514-1517. Centers for Disease Control and Prevention. Clinical Guidance for Group A Streptococcal Pharyngitis. Available at cdc.gov. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) Report, Group A Streptococcus. Available at cdc.gov. American Academy of Pediatrics. Red Book: Report of the Committee on Infectious Diseases. Group A Streptococcal Infections chapter. Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):e86-e102. World Health Organization. Guideline on the management of pharyngitis and prevention of rheumatic fever. Available at who.int.